E-mail this story
Amgen to pay Maryland $856,000 in drug marketing case
Drug company Amgen Inc. will pay the Maryland Medicaid system $856,474 to settle allegations that it illegally marketed and priced drugs used to treat anemia, rheumatoid arthritis and other diseases.
By Andrea K. Walker, The Baltimore Sun
January 4, 2013